EGFR and neoplasm: Therefore, as compared to anti-EGFR therapy alone, which had a similar impact on tumor volume, that BATs treatment established an anti-tumor immune response that could reject tumor rechallenge is critical to improving overall and disease-free survival [7, 46, 47].